8 results within Condition Category: Nervous System Diseases Remove filter Countries of recruitment: Finland Remove filter

• ISRCTN69044459 : Exercise therapy intervention for children and young adults with cerebral palsy

  Overall trial status

  Ongoing

  Recruitment status

  Recruiting

  Finland

  Nervous System Diseases

  Date assigned

  21/04/2017

• ISRCTN42686094 : RESCUE ESES: a Randomized European trial of Steroids versus Clobazam Usage for Encephalopathy with Electrical Status Epilepticus in Sleep

  Overall trial status

  Ongoing

  Recruitment status

  Recruiting

  Finland

  Nervous System Diseases

  Date assigned

  24/05/2013

• ISRCTN77172005 : Monitoring and treatment of obesity-related sleep disorders

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  Finland

  Nervous System Diseases

  Date assigned

  23/10/2012

• ISRCTN16202527 : Study to investigate the combination of methylprednisolone and interferon-beta in the treatment of multiple sclerosis

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  Finland

  Nervous System Diseases

  Date assigned

  24/04/2009

• ISRCTN31894936 : An open-label follow-on study to assess the ongoing safety of MBP8298 in subjects with secondary progressive multiple sclerosis

  Overall trial status

  Stopped

  Recruitment status

  Stopped

  Finland

  Nervous System Diseases

  Date assigned

  18/05/2007

• ISRCTN17517446 : A Multicentre, Randomised, Double Blind, Placebo Controlled, Multiple Ascending Dose, Safety, Tolerability, And Amyloid-Imaging Positron Emission Tomography (PET) Trial Of AAB 001 (ELN115727) In Patients With Mild To Moderate Alzheimer's Disease (AD)

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  Finland

  Nervous System Diseases

  Date assigned

  28/11/2005

• ISRCTN98373474 : A double-blind placebo-controlled multicenter study to evaluate the efficacy and safety of MBP8298 in subjects with secondary progressive multiple sclerosis (SPMS)

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  Finland

  Nervous System Diseases

  Date assigned

  20/09/2005

• ISRCTN68218781 : A Multi-center, Double Blind, Randomized, Placebo Controlled, Parallel Group Trial Investigating Methylprednisolone in Combination with Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  Finland

  Nervous System Diseases

  Date assigned

  01/04/2004